Scopa James Paul
Insider CIK 1356950 · CHMA 10% owner · CNAT Director · SNDX 10% owner · PCRX · RDUS 10% owner · TRIV Director · ADVM Director · PETX 10% owner · VSTM · CERC 10% owner · EPZM 10% owner · DICE Director · ALGS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2026-06-25 | 2026-06-29 | 5,860 | — | $0 | 5,860 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,520 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,450 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,666 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,500 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 3,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | U Tender | 2025-12-09 | 2025-12-10 | 10,333 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2025-06-25 | 2025-06-26 | 5,860 | — | $0 | 5,860 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-06-27 | 2024-06-28 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 8,823 | — | $0 | 8,823 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 30,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2024-02-07 | 2024-02-09 | 100,000 | $1.35 | $135.0K | 100,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-10-25 | 2023-10-27 | 91,541 | $0.13 | $11.9K | 91,541 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award | 2023-10-25 | 2023-10-27 | 183,083 | $0.76 | $139.1K | 183,083 | SEC↗ |
| DICE DICE Therapeutics, Inc. | D To issuer deriv | 2023-08-09 | 2023-08-09 | 21,250 | — | $0 | 0 | SEC↗ |
| DICE DICE Therapeutics, Inc. | D To issuer deriv | 2023-08-09 | 2023-08-09 | 13,800 | — | $0 | 0 | SEC↗ |
| DICE DICE Therapeutics, Inc. | D To issuer deriv | 2023-08-09 | 2023-08-09 | 8,261 | — | $0 | 0 | SEC↗ |
| DICE DICE Therapeutics, Inc. | D To issuer deriv | 2023-08-09 | 2023-08-09 | 12,096 | — | $0 | 0 | SEC↗ |
| DICE DICE Therapeutics, Inc. | D To issuer | 2023-08-09 | 2023-08-09 | 15,199 | — | $0 | 0 | SEC↗ |
| DICE DICE Therapeutics, Inc. | D To issuer | 2023-08-09 | 2023-08-09 | 25,722 | — | $0 | 0 | SEC↗ |
| DICE DICE Therapeutics, Inc. | G Gift | 2023-08-02 | 2023-08-03 | 220 | — | $0 | 27,922 | SEC↗ |
| DICE DICE Therapeutics, Inc. | G Gift | 2023-08-02 | 2023-08-03 | 2,200 | — | $0 | 25,722 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-07-20 | 2023-07-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DICE DICE Therapeutics, Inc. | G Gift | 2023-07-18 | 2023-07-19 | 2,200 | — | $0 | 28,142 | SEC↗ |
| DICE DICE Therapeutics, Inc. | G Gift | 2023-07-11 | 2023-07-13 | 300 | — | $0 | 30,342 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2023-06-09 | 2023-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DICE DICE Therapeutics, Inc. | G Gift | 2023-05-01 | 2023-05-02 | 6,923 | — | $0 | 30,642 | SEC↗ |
| DICE DICE Therapeutics, Inc. | G Gift | 2023-05-01 | 2023-05-02 | 6,923 | — | $0 | 15,199 | SEC↗ |
| DICE DICE Therapeutics, Inc. | S Sale | 2023-03-17 | 2023-03-21 | 10,000 | $29.05 | $290.5K | 23,719 | SEC↗ |
| DICE DICE Therapeutics, Inc. | G Gift | 2022-10-24 | 2023-03-21 | 30,719 | — | $0 | 22,122 | SEC↗ |
| DICE DICE Therapeutics, Inc. | G Gift | 2022-10-24 | 2023-03-21 | 30,719 | — | $0 | 33,719 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-06-23 | 2022-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2022-06-10 | 2022-06-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DICE DICE Therapeutics, Inc. | A Award deriv | 2022-06-07 | 2022-06-08 | 21,250 | — | $0 | 21,250 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2021-11-15 | 2021-11-17 | 50,000 | $2.18 | $109.0K | 3,334 | SEC↗ |
| DICE DICE Therapeutics, Inc. | P Buy | 2021-09-15 | 2021-09-16 | 6,000 | $17.00 | $102.0K | 55,841 | SEC↗ |
| DICE DICE Therapeutics, Inc. | A Award deriv | 2021-09-14 | 2021-09-16 | 8,261 | — | $0 | 8,261 | SEC↗ |
| DICE DICE Therapeutics, Inc. | A Award deriv | 2021-09-14 | 2021-09-16 | 8,200 | — | $0 | 8,200 | SEC↗ |
| DICE DICE Therapeutics, Inc. | A Award deriv | 2021-09-14 | 2021-09-16 | 5,600 | — | $0 | 5,600 | SEC↗ |
| DICE DICE Therapeutics, Inc. | A Award deriv | 2021-09-14 | 2021-09-16 | 12,096 | — | $0 | 12,096 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2021-05-12 | 2021-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2021-04-26 | 2021-04-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2020-06-23 | 2020-06-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-05-04 | 2020-05-05 | 23,334 | — | $0 | 46,666 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-05-04 | 2020-05-05 | 23,334 | $6.48 | $151.2K | 53,334 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2020-02-14 | 2020-02-14 | 10,000 | $13.75 | $137.5K | 30,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2019-08-15 | 2019-08-16 | 33,750 | — | $0 | 45,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2019-07-31 | 2019-08-02 | 11,250 | — | $0 | 11,250 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2019-05-06 | 2019-05-06 | 20,000 | $6.71 | $134.2K | 20,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2019-05-01 | 2019-05-03 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2017-06-22 | 2017-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RDUS Radius Health, Inc. | J Other | 2016-09-27 | 2016-09-29 | 713,849 | — | $0 | 1,427,698 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2016-06-23 | 2016-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-09 | 312,085 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-09 | 1,138,210 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-09 | 718,396 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion | 2016-03-08 | 2016-03-09 | 718,396 | — | $0 | 1,856,606 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion | 2016-03-08 | 2016-03-09 | 1,138,210 | — | $0 | 1,138,210 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion | 2016-03-08 | 2016-03-09 | 312,085 | — | $0 | 2,168,691 | SEC↗ |
| TRIV TriVascular Technologies, | D To issuer | 2016-02-03 | 2016-02-04 | 1,776,692 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | C Conversion deriv | 2015-10-20 | 2015-10-20 | 16,672,224 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | C Conversion | 2015-10-20 | 2015-10-20 | 595,436 | — | $0 | 595,436 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion deriv | 2015-07-21 | 2015-07-21 | 95,225 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion deriv | 2015-07-21 | 2015-07-21 | 13,000,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion deriv | 2015-07-21 | 2015-07-21 | 22,721,988 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion deriv | 2015-07-21 | 2015-07-21 | 16,066,669 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion | 2015-07-21 | 2015-07-21 | 10,426 | — | $0 | 10,426 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion | 2015-07-21 | 2015-07-21 | 2,488,171 | — | $0 | 2,498,597 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion | 2015-07-21 | 2015-07-21 | 1,423,566 | — | $0 | 5,681,544 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion | 2015-07-21 | 2015-07-21 | 1,759,381 | — | $0 | 4,257,978 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2015-06-11 | 2015-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TRIV TriVascular Technologies, | A Award deriv | 2015-05-22 | 2015-05-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2014-06-19 | 2014-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion deriv | 2014-06-06 | 2014-06-10 | 71,638 | — | $0 | 0 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion deriv | 2014-06-06 | 2014-06-10 | 184,242 | — | $0 | 0 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion deriv | 2014-06-06 | 2014-06-10 | 114,537 | — | $0 | 0 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion | 2014-06-06 | 2014-06-10 | 883,993 | — | $0 | 1,433,541 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion | 2014-06-06 | 2014-06-10 | 314,204 | — | $0 | 1,747,745 | SEC↗ |
| RDUS Radius Health, Inc. | J Other | 2014-06-06 | 2014-06-10 | 393,802 | — | $0 | 2,141,547 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion | 2014-06-06 | 2014-06-10 | 549,548 | — | $0 | 549,548 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-23 | 1,516,122 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-23 | 20,757,635 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-23 | 6,000,000 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-23 | 2,947,605 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-23 | 15,400,411 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-23 | 10,266,940 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-23 | 37,369 | — | $0 | 37,369 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-23 | 253,066 | — | $0 | 1,776,692 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-23 | 379,599 | — | $0 | 1,523,626 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-23 | 114,942 | — | $0 | 1,144,027 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-23 | 230,756 | — | $0 | 1,029,085 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-23 | 798,329 | — | $0 | 798,329 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2014-03-10 | 2014-03-12 | 600,000 | $20.02 | $12.01M | 2,751,048 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | J Other | 2014-03-03 | 2014-03-05 | 20,876 | — | $0 | 38,386 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | J Other | 2014-03-03 | 2014-03-05 | 15,310 | — | $0 | 17,937 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | J Other | 2014-03-03 | 2014-03-05 | 20,876 | — | $0 | 22,767 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | J Other | 2014-03-03 | 2014-03-05 | 12,247 | — | $0 | 12,393 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | J Other | 2014-03-03 | 2014-03-05 | 20,876 | — | $0 | 26,713 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | J Other | 2014-03-03 | 2014-03-05 | 1,000,000 | — | $0 | 3,351,048 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | J Other | 2014-03-03 | 2014-03-05 | 37,117 | — | $0 | 37,117 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-02-10 | 2014-02-11 | 466,666 | $29.25 | $13.65M | 2,413,819 | SEC↗ |
| TRIV TriVascular Technologies, | A Award deriv | 2013-11-01 | 2014-04-23 | 10,266,940 | $0.39 | $4.00M | 10,266,940 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2013-07-30 | 2013-08-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion deriv | 2013-07-30 | 2013-08-01 | 32,220 | — | $0 | 32,220 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion deriv | 2013-07-30 | 2013-08-01 | 265,837 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion deriv | 2013-07-30 | 2013-08-01 | 8,333,334 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | J Other | 2013-07-30 | 2013-08-01 | 16,716 | $11.00 | $183.9K | 1,026,815 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | P Buy | 2013-07-30 | 2013-08-01 | 165,265 | $11.00 | $1.82M | 1,192,080 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion | 2013-07-30 | 2013-08-01 | 1,010,099 | — | $0 | 1,010,099 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion deriv | 2013-07-02 | 2013-07-02 | 375,000 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion deriv | 2013-07-02 | 2013-07-02 | 1,333,333 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion deriv | 2013-07-02 | 2013-07-02 | 4,000,000 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | P Buy | 2013-07-02 | 2013-07-02 | 500,000 | $6.00 | $3.00M | 4,351,050 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion | 2013-07-02 | 2013-07-02 | 225,631 | — | $0 | 3,851,050 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion | 2013-07-02 | 2013-07-02 | 802,246 | — | $0 | 3,625,419 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion | 2013-07-02 | 2013-07-02 | 2,406,739 | — | $0 | 2,823,173 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion deriv | 2013-06-05 | 2013-06-06 | 1,176,472 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion deriv | 2013-06-05 | 2013-06-06 | 6,930,000 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion | 2013-06-05 | 2013-06-06 | 2,309,998 | — | $0 | 2,488,329 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion | 2013-06-05 | 2013-06-06 | 392,156 | — | $0 | 2,880,485 | SEC↗ |
| RDUS Radius Health, Inc. | P Buy deriv | 2013-04-23 | 2013-04-30 | 179,095 | $6.14 | $1.10M | 179,095 | SEC↗ |
| RDUS Radius Health, Inc. | P Buy deriv | 2013-04-23 | 2013-04-30 | 71,638 | $61.42 | $4.40M | 71,638 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-11 | 2013-03-13 | 500,000 | $27.86 | $13.93M | 2,790,479 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion deriv | 2012-02-01 | 2012-02-03 | 266,666 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion deriv | 2012-02-01 | 2012-02-03 | 2,500,000 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion deriv | 2012-02-01 | 2012-02-03 | 4,000,000 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion | 2012-02-01 | 2012-02-03 | 1,933,333 | — | $0 | 1,933,333 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2012-02-01 | 2012-02-03 | 100,000 | $10.00 | $1.00M | 2,033,333 | SEC↗ |